Jump to main content
Jump to site search

Issue 18, 2018
Previous Article Next Article

Cancer cell nucleus-targeting nanocomposites for advanced tumor therapeutics

Author affiliations

Abstract

Tumor therapeutic efficacy is determined, to a great extent, by the delivery efficiency of therapeutic drugs to their final targets. The cell nucleus has been proven to be the main interaction site for most therapeutic agents such as anticancer drugs, genes, free radicals, and heat. Therefore, it is highly expected that cell nucleus-targeting or nuclear membrane-penetrating nanotherapeutics would provide a more effective strategy than ordinary cell membrane-targeting ones for benefiting precise nanomedicine in humans' battles against cancer. This tutorial review presents a summary of the most recent progress achieved in the design, synthesis, and application of cell nucleus-targeting nanotherapeutics. We first discuss a number of design principles involved in cell nucleus-targeting nanotherapeutics, including size control, shape regulation, and surface modification. Next, we demonstrate the diverse applications of cell nucleus-targeting nanotherapeutics ranging from chemotherapy, gene therapy, photodynamic therapy, photothermal therapy to synergistic therapy. Moreover, a number of typical nanotherapeutics designed for enhanced therapeutic efficacy by targeting other subcellular organelles (such as mitochondria, lysosomes, and endoplasmic reticulum) are also briefly discussed. Finally, perspectives and challenges in this research field are proposed, in the hope of accelerating their translation into the clinic.

Graphical abstract: Cancer cell nucleus-targeting nanocomposites for advanced tumor therapeutics

Back to tab navigation

Publication details

The article was received on 29 Jan 2018 and first published on 31 Jul 2018


Article type: Tutorial Review
DOI: 10.1039/C8CS00081F
Citation: Chem. Soc. Rev., 2018,47, 6930-6946
  •   Request permissions

    Cancer cell nucleus-targeting nanocomposites for advanced tumor therapeutics

    L. Pan, J. Liu and J. Shi, Chem. Soc. Rev., 2018, 47, 6930
    DOI: 10.1039/C8CS00081F

Search articles by author

Spotlight

Advertisements